Statistics
Publications
30
Citations
3.2K
H-Index
25
Active since
1993
Michael Reilly is an author at GlaxoSmithKline (United States) specializing in pharmacology, medicinal chemistry, and drug discovery.
Publications per year
1993–2021
30
30
Design of amidobenzimidazole STING receptor agonists with systemic activity
Joshi M. Ramanjulu, G. Scott Pesiridis, Jingsong Yang et al. · Nature · 2018 · 865 citations
Philip A. Harris, Scott B. Berger, Jae Uk Jeong et al. · Journal of Medicinal Chemistry · 2017 · 475 citations · Full text
RIP1 Kinase Drives Macrophage-Mediated Adaptive Immune Tolerance in Pancreatic Cancer
Wei Wang, Jill M. Marinis, Allison M. Beal et al. · Cancer Cell · 2018 · 250 citations · Full text
Life Sciences, Immunology, Oncology +16
Extended pharmacodynamic responses observed upon PROTAC-mediated degradation of RIPK2
Alina Mares, Afjal H. Miah, Ian E. Smith et al. · Communications Biology · 2020 · 221 citations · Full text
1–5 of 30